4.5 Article

Respiratory system impedance with impulse oscillometry in healthy and COPD subjects: ECLIPSE baseline results

Journal

RESPIRATORY MEDICINE
Volume 105, Issue 7, Pages 1069-1078

Publisher

W B SAUNDERS CO LTD
DOI: 10.1016/j.rmed.2011.01.010

Keywords

Impulse oscillometry; ECLIPSE; Respiratory system impedance; Chronic obstructive pulmonary disease; Respiratory reactance

Funding

  1. GlaxoSmithKline
  2. Boehringer-Ingelheim
  3. Forrest Medical
  4. AstraZeneca
  5. Aeris
  6. Almirall
  7. Esteve
  8. Novartis
  9. Canadian Institutes of Health Industry (Wyeth)
  10. AstraZeneca (Australia)
  11. ECLIPSE
  12. Nycomed

Ask authors/readers for more resources

Rationale: Current assessment of COPD relies extensively on the use of spirometry, an effort-dependent maneuver. Impulse oscillometry (IOS) is a non-volitional way to measure respiratory system mechanics, but its relationship to structural and functional measurements in large groups of patients with COPD is not clear. Objectives: We evaluated the ability of IOS to detect and stage COPD severity in the prospective ECLIPSE cohort of COPD patients defined spirometrically, and contrasted with smoking and non-smoking healthy subjects. Additionally, we assessed whether IOS relates to extent of CT-defined emphysema. Methods: We measured lung impedance with IOS in healthy non-smokers (n = 233), healthy former smokers (n = 322) or patients with COPD (n = 2054) and related these parameters with spirometry and areas of low attenuation in lung CT. Measurements and main results: In healthy control subjects, 105 demonstrated good repeatability over 3 months. In the COPD group, respiratory system impedance was worse compared with controls as was frequency dependence of resistance, which related to GOLD stage. However, 29-86% of the COPD subjects had values that fell within the 90% confidence interval of several parameters of the healthy non-smokers. Although mean values for impedance parameters and CT indices worsened as GOLD severity increased, actual correlations between them were poor (r <= 0.16). Conclusions: IOS can be reliably used in large cohorts of subjects to assess respiratory system impedance. Cross-sectional data suggest that it may have limited usefulness in evaluating the degree of pathologic disease, whereas its role in assessing disease progression in COPD currently remains undefined. (C) 2011 Published by Elsevier Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available